ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED

ClinicalTrials.gov ID: NCT00790751

Public ClinicalTrials.gov record NCT00790751. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 4:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil (TA-1790) in Subjects With Generalized Erectile Dysfunction

Study identification

NCT ID
NCT00790751
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
VIVUS LLC
Industry
Enrollment
646 participants

Conditions and interventions

Interventions

  • avanafil Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2008
Primary completion
Jul 31, 2009
Completion
Jul 31, 2009
Last update posted
Jul 10, 2012

2008 – 2009

United States locations

U.S. sites
41
U.S. states
16
U.S. cities
36
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209
Research Site Homewood Alabama 35209
Research Site Tucson Arizona 85712
Research Site Sacramento California 95821
Research Site San Diego California 92120
Research Site San Diego California 92123
Research Site Waterbury Connecticut 06708
Research Site Clearwater Florida 33756
Research Site Clearwater Florida 33761
Research Site Coral Gables Florida 33134
Research Site Hialeah Florida 33012
Research Site Jacksonville Florida 32205
Research Site Jacksonville Florida 32259
Research Site Jupiter Florida 33458
Research Site Ocala Florida 34471
Research Site Pembroke Pines Florida 33024
Research Site Tampa Florida 33624
Research Site Atlanta Georgia 30308
Research Site Atlanta Georgia 30328
Research Site Wichita Kansas 67205
Research Site Madisonville Kentucky 42431
Research Site Shreveport Louisiana 71106
Research Site Kansas City Missouri 64114
Research Site Lawrenceville New Jersey 08648
Research Site Albany New York 12206
Research Site New York New York 10016
Research Site Cary North Carolina 27518
Research Site Charlotte North Carolina 28207
Research Site Charlotte North Carolina 28209
Research Site Harrisburg North Carolina 28075
Research Site Hickory North Carolina 28601
Research Site Raleigh North Carolina 27609
Research Site Salisbury North Carolina 28144
Research Site Wilmington North Carolina 28401
Research Site Winston-Salem North Carolina 27103
Research Site Beachwood Ohio 44122
Research Site Bala-Cynwyd Pennsylvania 19004
Research Site Lancaster Pennsylvania 17601
Research Site El Paso Texas 79925
Research Site Houston Texas 77074
Research Site Spring Texas 77386

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00790751, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2012 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00790751 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →